Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,392,060 papers from all fields of science
Search
Sign In
Create Free Account
SN-38-Loaded Polymeric Micelles NK012
Known as:
NK012
A formulation consisting of polymeric micelles loaded with the irinotecan metabolite SN-38 with potential antineoplastic activity. SN-38-loaded…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Improving the carrier stability and drug loading of unimolecular micelle-based nanotherapeutics for acid-activated drug delivery and enhanced antitumor therapy.
Xiaoxiao Shi
,
Shuang Bai
,
+7 authors
Zhigang Xu
Journal of materials chemistry. B
2018
Corpus ID: 104744873
Nanomedicines based on unimolecular micelles (UMs) have shown unique advantages such as high micellar stability, programmed cargo…
Expand
2015
2015
A phase II study of NK012, a polymeric micelle formulation of SN-38, in colorectal cancer patients who had received prior oxaliplatin-based regimen.
A. Tsuji
,
T. Hamaguchi
,
+9 authors
Y. Nambu
2015
Corpus ID: 73833489
3527 Background: NK012 is a micelle-forming macromolecular prodrug of SN-38, an active metabolite of irinotecan. In the completed…
Expand
2012
2012
Fabrication of biodegradable micelles with sheddable poly(ethylene glycol) shells as the carrier of 7-ethyl-10-hydroxy-camptothecin.
Qian Guo
,
Ping Luo
,
+5 authors
Jiahui Yu
Colloids and Surfaces B: Biointerfaces
2012
Corpus ID: 42399635
2012
2012
A phase I study of NK012 in combination with 5-fluorouracil with or without leucovorin in patients (pts) with advanced solid tumors.
Suzanne F. Jones
,
H. Burris
,
+6 authors
J. Bendell
2012
Corpus ID: 59545091
e13076 Background: NK012 is a micelle-forming macromolecular prodrug of EHC (7-ethyl-10-hydroxycamptothecin), also known as SN-38…
Expand
2011
2011
Phase II study of NK012 in relapsed small cell lung cancer.
E. Raefsky
,
D. Spigel
,
+8 authors
H. Burris
Journal of Clinical Oncology
2011
Corpus ID: 19167182
7079 Background: NK012 is a topoisomerase I (TI) inhibitor designed as a micelle-forming macromolecule to release a gradual and…
Expand
2009
2009
NK012. Topoisomerase I inhibitor apoptosis inducer oncolytic
Y. Matsumura
2009
Corpus ID: 78829410
2008
2008
A phase I dose-escalation study of NK012
H. Burris
,
J. Infante
,
+5 authors
Suzanne F. Jones
2008
Corpus ID: 56803084
2538 Background: NK012 is a micelle-forming macromolecular prodrug of EHC (7-ethyl-10-hydroxycamptothecin), also known as SN-38…
Expand
2008
2008
423 POSTER Phase I dose escalation study of NK012, polymer micelle of irinotecan metabolite SN-38, in patients with advanced cancer
D. Toshihiko
,
N. Fuse
,
+7 authors
Masaya Takanashi
2008
Corpus ID: 73207033
2008
2008
NOVEL SN-38-INCORPORATED POLYMERIC MICELLES, NK012, ERADICATE LUNG METASTASES AND INCREASE SURVIVAL IN THE MURINE RENAL CANCER MODEL
M. Sumitomo
,
F. Koizumi
,
+6 authors
M. Hayakawa
2008
Corpus ID: 71960932
2006
2006
Superior antitumor activity of NK012, 7-ethyl-10-hydroxycamptothecin-incorporating micellar nanoparticle, to irinotecan
Takeshi Onda
,
I. Nakamura
,
+5 authors
Masanobu Suzuki
2006
Corpus ID: 78192621
Proc Amer Assoc Cancer Res, Volume 47, 2006 3062 Irinotecan hydrochloride (CPT-11) is clinically used to treat various tumors…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE